Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction

Area of Science:

• Immunology
• Neurology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple organs, including the central nervous system (CNS).
• The serological markers associated with CNS involvement in SLE are not fully understood.
• Previous studies have suggested potential roles for anti-DNA antibodies and complement activity, but findings have been inconsistent.

Purpose of the Study:

• To investigate the serological profiles of patients with SLE during acute central nervous system (CNS) disease episodes.
• To determine the association of specific autoantibodies, including anti-DNA, anti-Sm, anti-RNP, and cold-reactive IgM antilymphocyte antibodies, with CNS manifestations in SLE.
• To explore the relationship between serological markers and the presence of extra-CNS disease activity.

Main Methods:

• Serologic studies were conducted on 25 patients with SLE experiencing 29 acute CNS disease episodes.
• Measurements included anti-DNA antibody levels, total serum hemolytic complement activity, cold-reactive IgM antilymphocyte antibodies, anti-Sm antibodies, and anti-RNP antibodies.
• Patients' clinical status, including CNS and extra-CNS disease manifestations, was assessed.

Main Results:

• Increased anti-DNA antibody and decreased complement activity were observed only in SLE patients with concurrent extra-CNS disease.
• Patients with isolated CNS disease showed no significant changes in these two serological markers.
• An increased incidence of anti-Sm antibodies was found in patients with CNS dysfunction compared to those without neuropsychiatric disease.
• No specific association was found between cold-reactive IgM antilymphocyte antibodies and ongoing CNS injury.
• The incidence of anti-RNP antibodies was not elevated in patients with CNS disease.

Conclusions:

• The findings do not support the direct involvement of DNA/anti-DNA complexes or lymphocytotoxic antibodies in SLE-related brain injury.
• An association between anti-Sm antibodies and CNS disease in SLE is suggested by the increased incidence observed.
• Further research is warranted to elucidate the role of anti-Sm antibodies in the pathogenesis of neuropsychiatric lupus.